During a Thursday press conference in the Oval Office, a man collapsed behind President Donald Trump while he was speaking alongside drugmakers about expanding Medicare coverage and lowering prices for the obesity treatments Zepbound and Wegovy.
Officials quickly rushed to assist after the incident, and members of the press were briefly escorted out of the room. Dr. Mehmet Oz, Administrator of the Centers for Medicare and Medicaid Services, supported the man’s head as he was lowered to the floor. The cause of the collapse remains unclear.
White House Press Secretary Karoline Leavitt told reporters that the man was a guest representing one of the attending health care companies, Eli Lilly or Novo Nordisk.
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
Roughly an hour later, President Trump resumed the event, noting that the guest had felt lightheaded but was now doing fine. The individual did not return to the Oval Office after the incident.
President Trump also announced a new agreement with Eli Lilly and Novo Nordisk to expand Medicare access and reduce costs for the two leading weight-loss drugs.
Author’s summary: During a White House event on weight-loss drugs, a company representative fainted behind President Trump; the man later recovered as the event continued without further incident.